These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10816499)

  • 1. The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).
    Boyce JD; Adler B
    Infect Immun; 2000 Jun; 68(6):3463-8. PubMed ID: 10816499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.
    Chung JY; Wilkie I; Boyce JD; Townsend KM; Frost AJ; Ghoddusi M; Adler B
    Infect Immun; 2001 Apr; 69(4):2487-92. PubMed ID: 11254611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic organisation of the capsule biosynthetic locus of Pasteurella multocida M1404 (B:2).
    Boyce JD; Chung JY; Adler B
    Vet Microbiol; 2000 Mar; 72(1-2):121-34. PubMed ID: 10699509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.
    Boyce JD; Adler B
    Infect Immun; 2001 Mar; 69(3):1943-6. PubMed ID: 11179380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system.
    Townsend KM; Boyce JD; Chung JY; Frost AJ; Adler B
    J Clin Microbiol; 2001 Mar; 39(3):924-9. PubMed ID: 11230405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capsule biosynthetic locus of Pasteurella multocida A:1.
    Chung JY; Zhang Y; Adler B
    FEMS Microbiol Lett; 1998 Sep; 166(2):289-96. PubMed ID: 9770287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
    Chung JY; Wilkie I; Boyce JD; Adler B
    Vaccine; 2005 Apr; 23(21):2751-5. PubMed ID: 15780722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors.
    Steen JA; Steen JA; Harrison P; Seemann T; Wilkie I; Harper M; Adler B; Boyce JD
    PLoS Pathog; 2010 Feb; 6(2):e1000750. PubMed ID: 20140235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular Polysaccharide Interferes with Biofilm Formation by
    Petruzzi B; Briggs RE; Tatum FM; Swords WE; De Castro C; Molinaro A; Inzana TJ
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162713
    [No Abstract]   [Full Text] [Related]  

  • 10. The key surface components of Pasteurella multocida: capsule and lipopolysaccharide.
    Harper M; Boyce JD; Adler B
    Curr Top Microbiol Immunol; 2012; 361():39-51. PubMed ID: 22373812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of the hyaluronic acid capsule of Pasteurella multocida.
    Guan L; Zhang L; Xue Y; Yang J; Zhao Z
    Microb Pathog; 2020 Dec; 149():104380. PubMed ID: 32645423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production.
    Smallman TR; Williams GC; Harper M; Boyce JD
    Microbiol Spectr; 2022 Apr; 10(2):e0019522. PubMed ID: 35404102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the ompA-types among ruminant and swine pneumonic strains of Pasteurella multocida exhibiting various cap-locus and toxA patterns.
    Vougidou C; Sandalakis V; Psaroulaki A; Siarkou V; Petridou E; Ekateriniadou L
    Microbiol Res; 2015 May; 174():1-8. PubMed ID: 25946323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasteurella multocida capsule: composition, function and genetics.
    Boyce JD; Chung JY; Adler B
    J Biotechnol; 2000 Sep; 83(1-2):153-60. PubMed ID: 11000471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasmid acquisition on potential virulence attributes of Pasteurella multocida.
    Lee MD; Wooley RE
    Avian Dis; 1995; 39(3):451-7. PubMed ID: 8561727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of capsule biosynthesis in serotype A strains of Pasteurella multocida.
    Watt JM; Swiatlo E; Wade MM; Champlin FR
    FEMS Microbiol Lett; 2003 Aug; 225(1):9-14. PubMed ID: 12900014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pasteurella multocida pathogenesis: 125 years after Pasteur.
    Harper M; Boyce JD; Adler B
    FEMS Microbiol Lett; 2006 Dec; 265(1):1-10. PubMed ID: 17107417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate vaccine antigens and genes in Pasteurella multocida.
    Adler B; Bulach D; Chung J; Doughty S; Hunt M; Rajakumar K; Serrano M; van Zanden A; Zhang Y; Ruffolo C
    J Biotechnol; 1999 Aug; 73(2-3):83-90. PubMed ID: 10486918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status.
    Ewers C; Lübke-Becker A; Bethe A; Kiebling S; Filter M; Wieler LH
    Vet Microbiol; 2006 May; 114(3-4):304-17. PubMed ID: 16427218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsule thickness and amounts of a 39 kDa capsular protein of avian Pasteurella multocida type A strains correlate with their pathogenicity for chickens.
    Borrathybay E; Sawada T; Kataoka Y; Okiyama E; Kawamoto E; Amao H
    Vet Microbiol; 2003 Dec; 97(3-4):215-27. PubMed ID: 14654292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.